期刊文献+

乙胺吡嗪利福异烟片中各组分的高效液相测定方法 被引量:8

HPLC determination of active components in Yi'an Biqin Lifu Yiyan tablets
在线阅读 下载PDF
导出
摘要 目的:建立高效液相色谱法测定乙胺吡嗪利福异烟片中盐酸乙胺丁醇、吡嗪酰胺、利福平和异烟肼含量。方法:盐酸乙胺丁醇选用了苯乙基异氰酸酯为衍生剂进行柱前衍生化,用C_(18)色谱柱,甲醇-水-冰醋酸(70∶30∶0.2)为流动相,流速1.0mL·min^(-1),检测波长220nm。异烟肼和吡嗪酰胺用C_(18)色谱柱,以乙腈-0.02mol·L^(-1)磷酸二氢铵(2∶98)为流动相,流速1.0mL·min^(-1),检测波长263nm。利福平色谱条件为C_(18)色谱柱,以甲醇-乙腈-0.075mol·L^(-1)磷酸二氢钾-1mol·L^(-1)枸橼酸(30∶30∶26∶4)为流动相,流速1.0mL·min^(-1),检测波长254nm。结果:盐酸乙胺丁醇、异烟肼、吡嗪酰胺及利福平分别在20~160,2~50,10~250,20~180μg·mL^(-1)的浓度范围内,呈良好的线性关系。结论:各成分测定方法简便,重现性好,特别是盐酸乙胺丁醇的衍生化方法反应迅速,条件容易控制,衍生化方法可靠,适用于抗结核固定剂量复合剂多成分的分离和含量测定。 Objective:To set up the method for the determination of ethambutol hydrochloride isoniazid, pyrazinamide, and rifampicin in Yi'an Biqin Lifu Yiyan tablets by HPLC. Method:Ethambutol hydrochloride with phenylethyl isocyanate by precolumn derivation were detected with C ls column, the mobile phase was methanol -water- glacial acetic acid (70: 30: 0. 2) and the flowing rate was 1.0 mL · min^-1 ,detected at 220 nm. Isoniazid and pyrazinamide in the tablets were separated on the column of C18, and the mobile phase consisted of acetonitrile -0. 02 mol · L^-1 ammonium dihydrogen phosphate (2: 98). The flowing rate was 1.0 mL · min^-1 with UV detection at 263 nm. The chromatographic conditions of rifampicin were as follows: C18 column,with a mixture the mobile phase of methanol -acetonitrile- 0. 075 mol ·L^- 1 potassium dihydrogen phosphate -1 mol ·L^- 1 citric acid (30: 30:26: 4), a flowing rate of 1.0 mL ·min^- 1, and the detective wavelength at 254 nm. Result:The linear ranges of ethambutol hydrochloride, isoniazid, pyrazinamide, and rifampicin were 20 - 160,2 - 50,10 - 250,20 - 180 μg·mL^-1, respectively. Conclusion:The determination method of different components appeared to be simple with a good reproducibility. Especially the derivating reaction of ethambutol hydrochloride,was rapid, reliable and controlled easily. The method can be used for the content determination of ethambutol hydrochloride in fixed - dose combination (FDC).
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第4期528-531,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 乙胺吡嗪利福异烟片 固定剂量复合剂 异烟肼 吡嗪酰胺 盐酸乙胺丁醇 利福平 Yi'an Biqin Lifu Yiyan tablets fixed - dose combination ( FDC ) isoniazid pyrazinamide ethambutol hydrochloride rifampicin
  • 相关文献

参考文献4

  • 1The Secretariat Managing the Global Partnership to Stop TB with Contributions from various stakeholders belonging to the Global Partnership. Frequently asked questions about the 4 - drug fixed - dose combination tablet recommended by the World Health Organization for treating tuberculosis. Global Drug Facility,2002:4.
  • 2Chenevier P, Massias L, Gueylard D,et al. Determination of ethambutol in plasma by high - performance liquid chromatography after pre- column derivatization. J Chromatogr B, 1998,708:310
  • 3.ChP(中国药典):Vol Ⅱ(二部)[M].,2000.Appendix(附录)XIE.
  • 4谭卫国,杨应周,程锦泉,吴清芳,张玉华,罗育希,严薇荣,钟球,王甦民.抗结核固定复合制剂与板式组合药治疗肺结核可行性的对照研究[J].中国防痨杂志,2005,27(4):209-214. 被引量:13

二级参考文献7

  • 1Bjorn Blomberg, Sergio Spinaci, Bernard Fourie,et al. The rational for recommending fixed-dose combination tablets for treatment of tuberculosis[J].Bulletin of the World Health Organization, 2001, 79 (1): 61~68.
  • 2Hongkong Chest Service/BMRC. Acceptability, compliance, and adverse reactions when isoniazid, rifampin, and pyrazinamide are given as a combined formulation or separately during three times weekly antituberculosis chemotherapy[J]. Am Rev Respir Dis,1989, 64: 36.
  • 3Chaulet P, Boulahbal F. Clinical trial of a combination of three drugs in fixed proportions for the treatment of tuberculosis[J]. Tuberculosis and Lung Disease, 1995, 76: 407~412.
  • 4Ohno M, Yamaguchi I, Yamamoto I, et. al. (2000) Slow N-acetyltransferase 2 genotype affects the incidence of INH and RMP-induced hepatotoxicity[J]. Intl J of Tuberc Lung Dis. 4(3), 256~261.
  • 5Huang,Yishin Chern Herngder, Su Wei jun,et al. (2002) Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for all anti-tuberculosis drugs-induced hepatitis[J]. Hepatology. 35, 883~889.
  • 6Management Sciences For Health. International drug price indicator guide(1991-1996)[M]. Arlington, VA , Management Sciences For Health/Washington DC, The World Bank, 1991~1996.
  • 7朱莉贞,严碧涯,马伟路,叶志中,张晨曦,陈志铨,苑松林,钟济和,夏祥新,黄建生,聂玉生,程杰.固定剂量复合剂卫非特/卫非宁治疗结核病的临床对照研究[J].中华结核和呼吸杂志,1998,21(11):645-647. 被引量:34

共引文献32

同被引文献37

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部